Krystal Biotech, Inc. (KRYS)
288.99
+4.42
(+1.55%)
USD |
NASDAQ |
May 06, 16:00
288.88
-0.11
(-0.04%)
Pre-Market: 20:00
Krystal Biotech SG&A Expense (TTM) : 114.19M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Scholar Rock Holding Corp. | 176.20M |
| Stoke Therapeutics, Inc. | 67.09M |
| Moderna, Inc. | 979.00M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| TG Therapeutics, Inc. | 181.70M |